Imiglucerase Patent Expiration

Imiglucerase is Used for treating Gaucher's disease. It was first introduced by Genzyme Corp in its drug Cerezyme on May 23, 1994.


Imiglucerase Patents

Given below is the list of patents protecting Imiglucerase, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cerezyme US5549892 Enhanced in vivo uptake of glucocerebrosidase Aug 27, 2013

(Expired)

Genzyme